Advertisement

Topics

Latest "Global Regional Iodine Market Research Report 2017 Report" News Stories

11:57 EDT 21st March 2019 | BioPortfolio

Here are the most relevant search results for "Global Regional Iodine Market Research Report 2017 Report" found in our extensive news archives from over 250 global news sources.

More Information about Global Regional Iodine Market Research Report 2017 Report on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Global Regional Iodine Market Research Report 2017 Report for you to read. Along with our medical data and news we also list Global Regional Iodine Market Research Report 2017 Report Clinical Trials, which are updated daily. BioPortfolio also has a large database of Global Regional Iodine Market Research Report 2017 Report Companies for you to search.

Showing "Global Regional Iodine Market Research Report 2017 Report" News Articles 1–25 of 53,000+

Thursday 21st March 2019

Eckert & Ziegler Strahlen- und Medizintechnik AG: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements

Eckert & Ziegler Strahlen- und Medizintechnik AG / Preliminary announcement on the disclosure of financial statements 21.03.2019 / 15:29 Preliminary announcement of the publication of quarterly reports and quarterly/interim statements transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. -------------------------------------------...


Eckert & Ziegler Strahlen- und Medizintechnik AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

Eckert & Ziegler Strahlen- und Medizintechnik AG / Preliminary announcement on the disclosure of financial statements 21.03.2019 / 15:22 Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. ...

Biogen: Fehlschlag verschärft die Notwendigkeit eines Deals!

Charlotte (www.aktiencheck.de) - Biogen-Aktienanalyse des Analysten Ying Huang von BofA Merrill Lynch Research: Im Rahmen einer aktuellen Aktienanalyse bringt Ying Huang, Aktienanalyst von BofA Mer...


Pharmacy Development Services (PDS) Announces Travis Wolff of Med-World Pharmacy as 2018 Pharmacist of the Year

2018 Pharmacist of the Year Named ORLANDO, Fla. (PRWEB) March 21, 2019 Travis Wolff, owner of Med-World Pharmacy, has been named 2018 Pharmacist of the Year by Pharmacy Development Services. PDS named the 2018 award winner at the 15th annual PDS Super-Conference (http://www.pdsconference.com). The Pharmacist of the Year award is given annually and honors one pharmacy owner’s dedication to impr...

City of Hope Scientists Showcase New Findings at the 2019 AACR Meeting

Researchers will discuss data and ongoing studies involving CAR T cell therapy, advanced nonsmall cell lung cancer, use of natural compounds and health equity. City of Hope, a world-renowned independent research and treatment center for cancer and diabetes, will showcase ongoing studies and data on chimeric antigen receptor (CAR) T cell therapy, immuno...

Fueling the Pharmaceutical Industry by Cutting-edge Design, InnoPack China to be Grandly Held in June

SHANGHAI, March 21, 2019 /PRNewswire/ -- With the development of science and technology, many high techniques and innovatively designed materials are gradually being integrated into pharmaceutical packages and drug delivery systems, and help pharmaceutical enterprises optimize administration routes and methods and improve efficacy and patient compliance. InnoPack China, hosted by China ...

PersonalMed Appoints Veteran Pharmacy Executive, Bill Letendre, MSPharm, MBA, as President

PersonalMed, LLC, today announced board member Bill Letendre, MSPharm, MBA, has been named president, effective immediately. As president, Letendre will have responsibility for all of the company's operations. He will report directly to the board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/2019032100...

Smiths Medical Announces Launch of Level 1® Convective Warmer

Next-generation convective warmer offers quiet, simple, precise temperature control during surgery. Smiths Medical, a leading global medical device manufacturer recently launched the Level 1® convective warmer. This next-generation high-flow convective warmer gives health care providers a quiet, simple and safe thermal care solution to help patients m...

Premier Inc. Analysis: Hospital-Associated Sepsis Decreased by 15% from 2015-2018

Sepsis-related mortalities, readmissions and incidences decline as hospital efforts to save lives yield success, but hospital-associated cases are 10 percent more likely to progress to septic shock, leading to a 20 percent increase in the cost per case Healthcare providers are becoming more adept at preventing and treating the top cause of hospital dea...

PhotoOpTx Announces Agreement with Jaeb Center for Health Research on Behalf of the DRCR Network

Diabetic macular edema (DME) is the most common condition that contributes to vision loss in persons with diabetes. PhotoOpTx, LLC has entered into an agreement with the Jaeb Center for Health Research Foundation acting on the behalf of the DRCR Network to provide devices for "A Pilot Study Evaluating Photobiomodulation Therapy for Diabetic Macular Edema". SOLON, Ohio (PRWEB) March 21, 2...

Customers’ experience leads to a highly successful outcome for Vetter at the 2019 CMO Leadership Awards

A win in all six core categories affirms Vetter as a trusted solution provider Vetter performs very well in customer-critical aspects Results directly reflect the experience of pharma and biotech companies in working alongside a trusted contractor More than 120 service providers assessed to determine the aw...

Rite Aid Stockholders Approve Reverse Stock Split

Rite Aid Corporation (NYSE: RAD) announced that its stockholders approved a reverse stock split of the company’s common stock at today’s Special Meeting of Stockholders. According to preliminary tabulations, with approximately 987 million eligible votes cast, stockholders voted 78% in favor of the reverse split. Rite Aid’s Board of Directors...

Pharmacists with additional skills can take 'overall clinical responsibility' for patients in A&E, study finds

Pharmacists with additional clinical skills training can take clinical responsibility for patients in hospital emergency departments, according to research published in the International Journal of Clinical Pharmacy.

EVOTEC AG TO REPORT FISCAL YEAR 2018 RESULTS ON 28 MARCH 2019

DGAP-News: Evotec AG / Key word(s): Miscellaneous 21.03.2019 / 14:26 The issuer is solely responsible for the content of this announcement. Hamburg, Germany, 21 March 2019: Evotec AG (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) will report its financial results for 2018 on Thursday, 28 March 2019. The Company is going to hold a conference call to discuss the results...

Cardiovascular, renal and metabolic (#CVRM) patients often have overlapping diseases and associated risk factors. At AstraZeneca, we continually evolve our clinical research with a goal to help advance clinical practice for preventive therapies for these

Cardiovascular, renal and metabolic ( #CVRM) patients often have overlapping diseases and associated risk factors. At AstraZeneca, we continually evolve our clinical research with a goal to help advance clinical practice for preventive therapies for these patients. pic.twitter.com/dnHJg5wpOc

Life-Sciences and Healthcare Communications Leaders John “Zeke” Czekanski and Scott Roberts Join Citrus Global Healthcare Communications Group as Managing Partners

Industry leaders John “Zeke” Czekanski and Scott Roberts have joined Citrus Global Healthcare Communications Group as Managing Partners. Zeke will oversee Citrus Scientific while Scott brings his extensive global market access and value experience in guiding Citrus Access. Together they will actively co-manage Citrus Strategy, providing insights enabli...

OncLive® Announces Ed Kim as Program Chair for Inaugural Global Expo

The three-day meeting will provide educational opportunities in all areas of oncology. OncLive®, the nation’s leading digital resource focused on providing oncology professionals with the most current and insightful information they need to provide the best patient care, announced Edward Kim, MD, FACP, a clinical oncology expert, as the program chai...

Today’s research is creating tomorrow’s lifesaving treatments and cures. But new policy proposals in Washington threaten to hamstring investment in innovation and jeopardize the very breakthroughs we’ve come to expect. Learn more: http://bit.ly/2TP

Today’s research is creating tomorrow’s lifesaving treatments and cures. But new policy proposals in Washington threaten to hamstring investment in innovation and jeopardize the very breakthroughs we’ve come to expect. Learn more: http://bit.ly/2TPwly9  #GoBoldly pic.twitter.com/y8YUBXVioy

Cofactor Genomics to Present on Predictive Immune Modeling at 2019 American Association for Cancer Research Annual Meeting

-- Presenting early data in collaboration with TriStar Technology Group -- Cofactor Genomics today announced that Natalie LaFranzo, the company’s Director of Scientific Projects and Market Development, will present at the 2019 Annual Meeting of the American Association for Cancer Research (AACR) being held at the Georgia World Congress Center in Atla...

Lilu’s Garden Predicts Record 2019 Hemp Harvest – First Ever Produced at Scale

New Aqueous Extraction process set to yield a million kilograms of CBD for wholesale in 2020 Lilu’s Garden, the largest hemp ingredient manufacturer in the Western Hemisphere, announced that its 2019 harvest is on track to yield upwards of 50 million lbs. of hemp or 1 million kilograms of isolated CBD and other non-psychoactive cannabinoids fo...

Most amusing reaction to $BIIB news today $NTRP +16% "Who cares how hard it is for alzheimer's drug development, We will take all the market share now aducanumab failed!" $AVXL bulls shouting -- "You forgot about us!"

Most amusing reaction to $BIIB news today $NTRP +16% "Who cares how hard it is for alzheimer's drug development, We will take all the market share now aducanumab failed!" $AVXL bulls shouting -- "You forgot about us!"

Auris Medical Holding (EARS) - Full-year results and near-term trial initiations

Edison Investment Research - Pharmaceuticals & healthcare - Auris Medical Holding: Auris recently announced its full-year 2018 financial results and provided an update on its active intranasal betahistine programs. R&D expenditure for the year was down roughly 65% compared to FY17, which reflects the shift to focus on earlier-stage program development. Auris plans to initiate the AM-125 Phase ...

Abzena Announces New Fully Integrated Developability and Optimization Service to Improve Lead Selection and De-risk Biologic Cell Line Development

Abzena, the leading biologics target to GMP partner research organisation (PRO), announced its Cambridge UK site has brought together its extensive discovery, immunogenicity assessment, protein engineering, formulation, bioassay and analytical expertise to launch a developability assessment and optimization service to assist customers in selecting and deve...

Samsung BioLogics Wins 2019 CMO Leadership Awards in All Six Core Categories Three Years in a Row

SEOUL, South Korea, March 21, 2019 /PRNewswire/ -- Samsung BioLogics, a global leading biopharmaceutical Contract Development and Manufacturing Organization (CDMO) based in South Korea, is pleased to announce that Samsung has won CMO Leadership Awards for all six core categories for the third year in a row in the 8th annual CMO Leadership Awards Reception presented by Life Science Leader.

Accurately Identifying Cancer-Causing Mutations from Archival Tumor Samples

Scientists at the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, report the development of LumosVar, a computer program that can help identify cancer-causing mutations from patient tumor samples. The study (“Leveraging Spatial Variation in Tumor Purity for Improved Somatic Variant Calling of Archival Tumor Only Samples”) appears in Frontiers in Oncology. ...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks